Kamfanonin da aka rufe a cikin kasuwar magungunan ganyayyaki sune KPC Products Inc. (California, US), NEXIRA (Normandy, Faransa), HISHIMO PHARMACEUTICALS (Rajasthan, India), Schaper & Brümmer GmbH & Co. KG (Salzgitter, Jamus), Sydler Group of Companies (Indiya), 21ST Century HealthCare, Inc. (Arizona, US), Zoic Pharmaceuticals (Punjab, India), Herbally Yours, Inc. (Arizona, US), Pharma Nord BV (Vejle, Denmark), NATURLAND (Gräfelfing, Jamus) da ƙarin bayanan 'yan wasa.
Tasirin COVID-19:
Bukatar Magungunan Ganye Ya Karu saboda Haɓaka Hankalin Lafiya, cutar ta COVID-19 ta shafi tsarin kiwon lafiya da sarƙoƙin samar da magunguna sosai.An sami ƙarancin magani a duk duniya saboda babban hauhawar hauhawar asibitocin da ke da alaƙa da COVID-19.Bugu da ƙari, R&D da ayyukan masana'antar magunguna suma sun sami shingen hanya yayin bala'in.
Koyaya, samfuran ganye sun sami haɓaka yayin da masu amfani suka ƙara sanin lafiyarsu da jin daɗinsu.Ƙara mai da hankali kan rigakafi ya haifar da buƙatar samfuran magunguna da kayan abinci daban-daban tare da kayan lambu.Waɗannan abubuwan sun buɗe sabbin dama ga 'yan wasan kasuwa yayin lokacin bala'in.
Buƙatar Magungunan Halitta da Kayan Aiki don haɓaka Ci gaban
Ci gaban Kasuwar Magungunan Ganye yana tasiri ta hanyar hauhawar buƙatar samfur don dalilai na likita a cikin ƙasashe masu tasowa.Ana amfani da kayan ganye sosai don kusan duk ƙananan gunaguni na lafiya.Masu amfani kuma suna juyawa zuwa kayan kwalliya da samfuran kulawa na sirri tare da abubuwan halitta da na halitta saboda babban aminci.Don cin gajiyar wannan yanayin, samfuran kyau da kayan kwalliya suna gabatar da sabbin nau'ikan samfura tare da kayan lambu.Abubuwan da aka ambata za su fitar da bukatar kasuwa sosai.
Koyaya, tsauraran ka'idoji masu alaƙa da shigo da amfani da albarkatun ganye a cikin abinci, magunguna, da aikace-aikacen kayan kwalliya na iya kawo cikas ga ci gaban kasuwa kaɗan.
Lokacin aikawa: Fabrairu-09-2022